Ocugen to Present at the 2024 Cell & Gene Meeting on the Mesa
MALVERN, Pa., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused...
Day: October 2, 2024
Vera Therapeutics Announces Late-Breaking Oral Presentation of ORIGIN Phase 2b Long-term Results at the American Society of Nephrology Kidney Week 2024
Two informational posters for ORIGIN Phase 3 and ORIGIN Extend trials of atacicept in IgAN accepted for presentation at Kidney...
Vera Therapeutics Announces Expanded Atacicept Development Program In Multiple Autoimmune Kidney Diseases
PIONEER study expands the investigation of atacicept into a broad definition of IgA nephropathy and into multiple autoimmune glomerular diseases,...
Genenta Secures Approval for Innovative Trial for Metastatic Renal Cell Cancer
Glioblastoma study achieves milestone with successful dose escalation, setting stage for Phase 2MILAN and NEW YORK, Oct. 02, 2024 (GLOBE...
The Ensign Group Acquires Healthcare Campus in Nebraska
SAN JUAN CAPISTRANO, Calif., Oct. 02, 2024 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group...
Oculis Announces Appointment of Daniel S. Char as Chief Legal Officer
ZUG, Switzerland, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Mr. Char brings extensive experience in leading legal, compliance and corporate governance...
Oculis Announces Appointment of Daniel S. Char as Chief Legal Officer
Mr. Char brings extensive experience in leading legal, compliance and corporate governance functions in successful biotech and medical device companiesThe...
Nexstim Receives NBS System 5 Order from European Customer
Press release, Helsinki, 2 October 2024 at 9 AM (EEST) Nexstim Receives NBS System 5 Order from European Customer Nexstim...
EssilorLuxottica Completes Acquisition of Supreme® from VF Corporation
EssilorLuxottica Completes Acquisition of Supreme® from VF Corporation Paris, France and Denver, Colorado (USA) (October 2, 2024 – 7am CEST)...
EssilorLuxottica Completes Acquisition of a Majority Stake in Heidelberg Engineering
EssilorLuxottica Completes Acquisitionof a Majority Stake in Heidelberg Engineering Paris, France and Heidelberg, Germany (October 2, 2024 – 7am CEST) –...
CARBIOS announces half-year 2024 financial results and presents its industrial and commercial progress
Construction progress of world’s first PET enzymatic biorecycling plant in France: in line with production targets in 2026Commercial development:...
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ORLANDO, Fla., Oct. 01, 2024 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”) today announced that a majority...
COSCIENS Biopharma Announces Appointment of Pierre Labbé as Director
TORONTO, ONTARIO, Oct. 01, 2024 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (NASDAQ: CSCI) (TSX: CSCI) (“COSCIENS” or the “Company”), a...
Vision Sensing Acquisition Corp. Announces Intention to Extend the Period to Consummate Its Initial Business Combination to November 3, 2024
NEW YORK, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Vision Sensing Acquisition Corp. (NASDAQ: VSACU, VSAC, VSACW) (the “Company”) a special...
Pliant Therapeutics Appoints Gary Palmer, M.D. as Senior Vice President of Medical Affairs
Former Bristol Myers Squibb Global Medical Affairs Lead brings over 25 years of experience to Pliant SOUTH SAN FRANCISCO, Calif.,...
BioAge Labs Announces Closing of Initial Public Offering, Full Exercise of Underwriters’ Option to Purchase Additional Shares and Closing of the Concurrent Private Placement
RICHMOND, Calif., Oct. 01, 2024 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (“BioAge”) (Nasdaq: BIOA), a clinical-stage biopharmaceutical company developing therapeutic...
Gyre Therapeutics to Present at 8th Annual H.C. Wainwright MASH Investor Conference
SAN DIEGO, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), a self-sustainable, commercial-stage biotechnology company with clinical...
BrightSpring Health Services, Inc. to Announce Third Quarter 2024 Financial Results on November 1, 2024
LOUISVILLE, Ky., Oct. 01, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG) announced today...
Kids Help Phone Launches the KHP Innovation and Applied Research Accelerator for Youth Mental Health on the Elevate Stage
The acceleratorKHP will disrupt the future of youth mental health support in Canada TORONTO, Oct. 2, 2024 /CNW/ - Kids...
Curve Therapeutics further strengthens leadership team with the appointment of Andre Hoekema as new Chair of Board
Dr Hoekema brings over four decades of successful biotech and life science leadershipDr Cora Griffin appointed to head up business...